华大基因：李宁辞去公司副总经理职务

Company Overview - BGI Genomics (SZ 300676) announced on November 12 that Mr. Li Ning has resigned from his position as Vice General Manager due to work arrangements, but will continue to serve as a director of the company and hold positions in its controlling subsidiaries [1] Financial Performance - For the fiscal year 2024, BGI Genomics' revenue composition is projected to be 99.36% from the genomics application industry and 0.64% from other businesses [1] Market Position - As of the report date, BGI Genomics has a market capitalization of 20.7 billion yuan [1]